Representatives from the drugmaker Mylan want to meet with Sen. Chuck Grassley, R-Iowa, to discuss a probe into whether the company bilked Medicaid out of $1.27 billion, according to a published report.
Mylan, which produces the allergy drug EpiPen, wants to meet with Grassley on June 7 to discuss a subpoena threat over documents pertaining to Medicaid’s rebate program, according to a report in the Street.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.